68Ga-PSMA PET/CT prostate cancer radiotherapy re-treatment

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
25 Nov 2020
Historique:
received: 22 10 2020
revised: 18 11 2020
accepted: 23 11 2020
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 2 12 2020
Statut: epublish

Résumé

(1) Purpose: To investigate the role of

Identifiants

pubmed: 33255681
pii: biomedicines8120536
doi: 10.3390/biomedicines8120536
pmc: PMC7761444
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : RF-2016-02364230
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG 20476

Références

J Clin Oncol. 2018 Feb 10;36(5):446-453
pubmed: 29240541
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):889-97
pubmed: 21277113
Adv Urol. 2012;2012:921674
pubmed: 22693495
Nat Rev Urol. 2020 Aug;17(8):469-481
pubmed: 32606361
Clin Genitourin Cancer. 2013 Mar;11(1):27-32
pubmed: 23010414
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
Clin Cancer Res. 1997 Jan;3(1):81-5
pubmed: 9815541
Eur Urol. 2020 May;77(5):614-627
pubmed: 32146018
Lancet Oncol. 2019 Sep;20(9):1286-1294
pubmed: 31375469
BMC Cancer. 2020 Apr 29;20(1):362
pubmed: 32349700
Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96
pubmed: 24983957
Med Phys. 2010 Aug;37(8):4078-101
pubmed: 20879569
BMC Cancer. 2014 Sep 15;14:671
pubmed: 25223986
Eur Urol. 2018 Oct;74(4):455-462
pubmed: 30227924
Clin Oncol (R Coll Radiol). 2020 May;32(5):327-329
pubmed: 31973898
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29
pubmed: 24399786
JAMA. 2008 Jun 18;299(23):2760-9
pubmed: 18560003

Auteurs

Paola Caroli (P)

Unit of Nuclear Medicine, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Sarah Pia Colangione (SP)

Department of Radiotherapy, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Ugo De Giorgi (U)

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Giulia Ghigi (G)

Department of Radiotherapy, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Monica Celli (M)

Unit of Nuclear Medicine, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Emanuela Scarpi (E)

Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, Via Maroncelli 40, 47014 Meldola, Italy.

Manuela Monti (M)

Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, Via Maroncelli 40, 47014 Meldola, Italy.

Valentina Di Iorio (V)

Oncology Pharmacy, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Anna Sarnelli (A)

Unit of Medical Physics, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Giovanni Paganelli (G)

Unit of Nuclear Medicine, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Federica Matteucci (F)

Unit of Nuclear Medicine, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Antonino Romeo (A)

Department of Radiotherapy, Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Classifications MeSH